1 Product identity
Ingredient risk
Contains restricted ingredients

Ashwagandha 300 mg

BrandJarrow FormulasBotanical Capsule 6 ingredients 1 banned 1 caution DSLD #307555
Net contents: 120 Veggie Capsule(s)
Target: Adults and Children 4 years and above
DSLD entry: 2024-01-24
2 Ingredients (6)
IngredientGroupSafety
Ashwagandha Root Extract AshwagandhaBanned in ≥1 country
Microcrystalline CelluloseCellulose
Hydroxypropyl MethylcelluloseHypromellose
WaterWater
Magnesium StearateMagnesiumUse with Caution
Silicon DioxideSiliconGenerally Safe
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⛔ Contains an ingredient banned in ≥1 country
Ashwagandha  🇩🇰 🇧🇪 🇪🇺 — Banned April 2023 following DTU risk assessment. All products withdrawn.
⚠️ Use with caution — restricted in some markets
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Ashwagandha — Banned in ≥1 country
⚠ Thyroid stimulation
⚠ HEPATOTOXICITY (rare but serious case reports)
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
Silicon — Generally Safe
⚠ Very low toxicity
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID307555
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2024-01-24
6 More from Jarrow Formulas
View Jarrow Formulas Safety Scorecard → 9 products
BoneUpBoneUpBoneUp 3 Per DayBorage Seed Oil 1200 mgEvening Primrose 1300 mgL-Tryptophan 500 mg
7 Cite this page
Vancouver
Pkhakadze G. Ashwagandha 300 mg — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Jun 25]. Available from: https://supplement.ge/products/ashwagandha-300-mg-307555/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG